Oct 23, 2026 03:15AM
Oct 23, 2026 03:15AM
Aug 3, 2026 04:05PM
Jul 14, 2026 04:05PM
Jul 14, 2026 04:05PM
Jun 8, 2026 06:57AM
Mar 31, 2026 04:05PM ORIC selects 400 mg rinzimetostat dose for phase 3 prostate cancer trial
Mar 31, 2026 04:05PM
Mar 9, 2026 02:27PM
Mar 9, 2026 10:06AM
Oct 30, 2024 04:29PM
Jul 9, 2024 07:30AM
Jan 9, 2023 08:19AM
Jan 9, 2023 08:00AM ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming Milestones
Jan 9, 2023 08:00AM
Nov 7, 2022 04:05PM
Nov 7, 2022 04:05PM
Mar 21, 2022 04:00PM
Mar 21, 2022 04:00PM
Jan 10, 2022 08:00AM
Jan 10, 2022 08:00AM ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming Milestones
Dec 13, 2021 04:17PM
Dec 13, 2021 04:15PM
Dec 13, 2021 04:15PM
Oct 7, 2021 08:55AM
Oct 7, 2021 08:55AM
Oct 7, 2021 08:55AM
Sep 21, 2021 06:30AM ORIC Pharmaceuticals Announces Update on ORIC-533, a Highly Potent, Orally Bioavailable Small Molecule CD73 Inhibitor
Sep 21, 2021 06:30AM
Aug 10, 2021 04:05PM
Aug 10, 2021 04:05PM
Jun 28, 2021 08:08AM
Jun 28, 2021 08:00AM
Jun 28, 2021 08:00AM
Jun 2, 2021 04:55PM ORIC Pharmaceuticals Reports Initial Clinical Data Being Presented at ASCO from Phase 1b Trial of ORIC-101 in Combination with Nab-Paclitaxel
Jun 2, 2021 04:55PM
Mar 23, 2021 04:05PM
Jan 11, 2021 06:43AM
Jan 11, 2021 06:30AM
Jan 11, 2021 06:30AM
Dec 21, 2020 06:34AM
Dec 21, 2020 06:30AM ORIC Pharmaceuticals Announces Initiation of Expansion Cohorts in Phase 1b Study of ORIC-101
Dec 21, 2020 06:30AM
Nov 5, 2020 04:05PM
Nov 5, 2020 04:05PM
Oct 19, 2020 04:02PM
Oct 19, 2020 04:02PM
Aug 5, 2020 04:10PM
Aug 5, 2020 04:10PM ORIC Pharmaceuticals Reports Second Quarter 2020 Financial and Operational Update
Aug 5, 2020 04:05PM

335,227 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All